sur Form Bio
Form Bio to Showcase AI-Driven AAV Gene Therapy Innovations at ASGCT 2024
On May 7-11, 2024, Form Bio will participate in the 27th annual meeting of the American Society of Gene and Cell Therapy (ASGCT) in Baltimore, Maryland. The company is set to deliver multiple vital presentations focusing on the advancement of gene therapy using artificial intelligence.
Among the key presentations, Dr. Amicia Elliott will discuss the enhancement of AAV vector design through advanced sequencing techniques. This session, along with other workshops and symposiums, aims to bridge the gap from preclinical developments to clinical success, particularly highlighting the role of AI in optimizing gene therapy constructs for improved safety, efficiency, and likelihood of success.
Additional engagements at the meeting include interactive workshops and "Meet the Expert" sessions, which promise further insights into AAV gene therapy, shared through collaboration with other industry leaders such as Solid Biosciences and Taysha Gene Therapies.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Form Bio